Mabgenex
mAbGenEx is a biotechnology company focused on developing protein-driven biologics for healthcare. They combine traditional experimental methods with advanced ML-driven antibody design to create antibody libraries. This unique approach allows them to discover and develop antibodies with high specificity and sensitivity at unprecedented speeds for both diagnostics and therapeutics, aiming to positively impact human health-span. Their core platforms include PrecinAb™, an AI/ML assisted antibody discovery platform, and OptinAb™, a cell surface display based platform for optimized next-gen antibodies. Their research focus includes developing therapeutics such as snake anti-venom using monoclonals and oncology treatments targeting GPCRs, as well as point-of-care diagnostics for infectious diseases. The company was founded in 2018 and is based in Hyderabad, India.
Mabgenex
mAbGenEx is a biotechnology company focused on developing protein-driven biologics for healthcare. They combine traditional experimental methods with advanced ML-driven antibody design to create antibody libraries. This unique approach allows them to discover and develop antibodies with high specificity and sensitivity at unprecedented speeds for both diagnostics and therapeutics, aiming to positively impact human health-span. Their core platforms include PrecinAb™, an AI/ML assisted antibody discovery platform, and OptinAb™, a cell surface display based platform for optimized next-gen antibodies. Their research focus includes developing therapeutics such as snake anti-venom using monoclonals and oncology treatments targeting GPCRs, as well as point-of-care diagnostics for infectious diseases. The company was founded in 2018 and is based in Hyderabad, India.